Dec 18, 2025Forteenswith obesity, the American Academy of Pediatrics recommends medication as a supplement to "health behavior and lifestyle treatment." What lifestyle changes are needed alongside aGLP-1medication? Medication has to be within the realm of a lifestyleprogram. If we prescribeGLP-1medications to ateen, there has to be family buy-in.
Apr 30, 2025Despite the rapid increase in glucagon-like peptide-1 receptor agonist (GLP-1) use for management of weight among adolescents (ages 12-18 years), there is limited guidance on associated behavioral health considerations. Adolescents onGLP-1therapyrepresent a potentially vulnerable population at risk of experiencing medical and psychosocial effects of obesity and comorbidities, as well as ...
Oct 13, 2025Purpose of Review The impact ofGLP1receptor agonist (GLP1-RA) medications oneatingdisorders is not established in large scale clinical trials with adult or pediatric populations. WhetherGLP1-RA improve or worseneatingdisorders is an important clinical question. This review integrates emerging evidence and clinical experience to offer guidance for pediatricGLP1-RA prescribing in the ...
Apr 1, 2025We highlight the importance of mental health care for obesity treatment, with a focus on disorderedeatingbehaviors and their intersection with obesity and pharmacologic treatment of obesity. Nutrition remains an important issue for obesity prevention and management, and we highlight nutritional concerns duringGLP-1RAtherapy.
Evaluating appetite/satiety hormones andeatingbehaviours as predictors of weight loss maintenance withGLP-1RAtherapyin adolescents with severe obesity Megan O. Bensignor, 717 Delaware Ave SE, Minneapolis, MN 55414, USA.
Thisprogramintegrates the appetite-regulating benefits ofGLP-1therapywith comprehensive nutritional guidance, optimizing the path to sustainable weight loss and improved health outcomes.
Mar 4, 2025Obesity remains highly prevalent among children in the United States and is associated with an ever-increasing burden of obesity-related diseases. Effective pediatric obesity prevention and treatment will require both societal interventions and health care system innovation. One recent advancement is the approval of glucagon-like peptide-1 receptor agonists (GLP-1RAs) for use in adolescents ...
Oct 3, 2025Yes, specialized training in youthGLP-1counseling is emerging as pediatric prescriptions have surged 700% since 2020. The Commission on Dietetic Registration offers certificates in pediatric obesity management, and universities like UT San Antonio and University of Florida provide GLP-1-specific training for nutritionists working with children ages 6-17 on these medications.
Learn how Petra integratesGLP-1guidance withmindfuleatingstrategies for sustainable, compassionate weight management.
Trusted clinicians: Licensed therapists experienced in behavioral health, emotionaleating,andlifestyle change.GLP-1medications are powerful, but they aren't magic. Andtherapyisn't a quick fix either. Both are tools. Together, they can help people not only lose weight but also gain confidence, balance, and long-term resilience.
Stay ahead with Fox News Health - Dive into breaking medical news and wellness trends. Find information on women's health, men's health and health education tips with Fox.
Explore HealthDay for comprehensive health topics, latest medical news, and wellness tips. Trusted for accuracy and expertise.
2 days agoSide effects onGLP-1medications are common but they don't have to derail your progress. With the right dietary strategies andGLP-1dietitian support, most people can significantly improve tolerance, protect muscle mass, and feel more confident navigating treatment.
2 days agoGLP-1stands for Glucagon-Like Peptide-1, a natural hormone your body produces that helps regulate blood sugar, appetite, digestion, and how full you feel aftereating.
5 days agoDining out onGLP-1sis possible. Learn how to order comfortably, manage portions, and navigate social meals without overdoing it.
Everyday Health inspires and empowers people to live their healthiest lives, every day, through trusted, medically reviewed information and expert health advice from the nation's leading ...
Leave a Reply You must be logged in to post a comment.
Jan 30, 2025How dangerous are Ozempic andGLP-1sforthose witheatingdisorders? Discover their risks, impact on recovery, and the role of diet culture.
+on+Your+Journey.jpg "Top 10 Spiritual Life Coaches Near Me - Sofia Health")
Find the top Spiritual Life Coaches. Make an appointment online instantly! Sofia helps you find Spiritual Life Coaches with availability. It's free!
GLP-1saffect the way your body processes food. Learn how to adjust your diet to get the most out of yourGLP-1andminimize side effects.
Dec 8, 2025Insulin treatment is essential for individuals with type1diabetes because the hallmark of type1diabetes is absent or near-absent β-cell function. In addition to hyperglycemia, insulinopenia can contribute to other metabolic disturbances like hypertriglyceridemia and ketoacidosis as well as tissue catabolism that can be life threatening.
If you're using aGLP-1medication for obesity treatment, you've probably noticed changes in your appetite, digestion and even how you think about food. These medications are powerful tools for managing weight and improving metabolic health, but they work best when combined with balanced, nourishing meals.GLP-1medications are designed to help you feel full longer aftereatingsmaller ...
Feb 25, 2025GLP-1drugs like Wegovy and Zepbound are safe and effective for adolescents. Some doctors and health organizations have urged caution when prescribing weight loss drugs to adolescents due to potential mental health risks. Healthcare providers are sharing the top emotional impacts they consider before prescribingGLP-1drugs forteens.
Glucagon-like peptide1receptor agonists and combination medications (hereafter collectively referred to asGLP-1s) are shifting the treatment landscape for obesity. However, real-world challenges and limited clinician and public knowledge on ...
Aug 26, 2025Background: Despite the rapid increase in glucagon-like peptide-1 receptor agonist (GLP-1) use for management of weight among adolescents (ages 12-18 years), there is limited guidance on associated behavioral health considerations. Adolescents onGLP-1therapyrepresent a potentially vulnerable population at risk of experiencing medical and psychosocial effects of obesity and comorbidities ...
Apr 17, 2024Lizzie, a 13-year-old with insulin resistance, has found promise inGLP-1medications like Wegovy, supported by her dedicated mother, Jackie, amidst their journey toward metabolic health.
Adolescents onGLP-1therapyrepresent a potentially vulnerable population at risk of experiencing medical and psychosocial effects of obesity and comorbidities, as well as side effects and behavioral implications of the medications. Method: This perspective discusses behavioral and psychosocial considerations for adolescents seekingGLP-1s.